News
Pennsylvania looks to be getting millions from a biopharma company for violating anti-kickback laws. Gilead Sciences, Inc.
GSK expands Medicines Patent Pool deal to allow generic production of cabotegravir for HIV treatment
GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for cabotegravir, allowing it to be produced by three generic drugmakers and supplied to ...
43m
Hip Hop Vibe on MSNYung Miami HIV Diagnosis Rumor Debunked: What the Internet Got WrongRumors circulated this weekend alleging Yung Miami, of City Girls, was diagnosed with HIV.
Massachusetts AG Campbell secures $1.6 million for the state's Medicaid in a settlement with Gilead over illegal kickbacks ...
Gilead Sciences (GILD) stock slips as the company agrees to pay $202M to settle allegations that its HIV drug promotion program violated U.S. law. Read more here.
In last week’s Supreme Court ruling, the justices allowed federal agencies to proceed with their reduction-in-force, or RIF, ...
NHS England has agreed to reimburse Vertex's newest cystic fibrosis medicine. Meanwhile, Merck advanced its once-monthly PrEP ...
Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...
The Senate is poised to vote this week on President Donald Trump's rescissions package requesting roughly $9.4 billion in ...
Kenya has been picked among nine countries for the trials of the new injectable HIV prevention drug that has been rolled out ...
Global deaths from AIDS have dropped to their lowest levels in more than 30 years, but US funding cuts could soon reverse that progress.
The U.S. Senate will begin voting as soon as Tuesday on President Donald Trump's request to slash $9.4 billion in spending on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results